• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Microarray Markets - Product Image

Microarray Markets

  • ID: 332501
  • August 2013
  • Region: Global
  • 202 Pages
  • TriMark Publications
Global Microarray Market to Catapult to $7.4 Billion by 2018

FEATURED COMPANIES

  • Affymetrix
  • Cancer Genetics, Inc
  • Great Basin Corporation
  • Meso Scale Discovery
  • Partek, Inc
  • Roche NimbleGen, Inc
  • MORE

Microarray technologies multiplex and miniaturize the analysis of tens of thousands of molecules for a variety of assays, including drug binding, molecular interactions, enzyme activity and pathway identification. These microarrays, which include DNA microarrays, protein microarrays, tissue microarrays, low complexity microarrays and carbohydrate microarrays, are excellent tools for gene expression profiling, biomarker profiling and diagnostics.

Pharmaceutical and biotechnology researchers use microarrays to streamline drug target identification, selection, validation and predictive testing. Rapid growth in the clinical research and diagnostic devices markets holds great potential for applications of microarray technology, including basic research, clinical trials and diagnostic devices.

This report describes the specific segment of the microarray market aimed at the analysis of proteins and DNA. It examines various microarray platforms and the technologies that are utilized in hospitals, clinics, commercial laboratories and research institutions to detect DNA and proteins for the purpose of drug discovery, disease diagnosis and disease monitoring. This report also examines companies that are actively developing and marketing microarray instrumentation or microarray biochips. Detailed tables and charts with sales forecasts and marketshare data are also included.

Global Microarray Market to Catapult to $7.4 Billion by 2018

FEATURED COMPANIES

  • Affymetrix
  • Cancer Genetics, Inc
  • Great Basin Corporation
  • Meso Scale Discovery
  • Partek, Inc
  • Roche NimbleGen, Inc
  • MORE

1. Overview
1.1 Statement of Report
1.2 Scope of the Report
1.3 Objectives
1.4 Methodology
1.5 Executive Summary

2. The Commercial Opportunity for Microarrays
2.1 Markets Served by Microarray Technologies
2.1.1 Basic Research Markets
2.1.2 Translational Medicine Markets
2.1.3 Molecular Diagnostic Markets
2.1.4 Specialized/Applied Markets
2.2 Microarray Market Analysis
2.3 Market Drivers
2.4 Market Restraints for Microarrays
2.5 Key Players and Market Share for Major Players
2.6 Strategic Trends and Competitive Landscape for Microarrays
2.7 Marketing and Distribution

3. Microarray Overview
3.1 History of Microarrays
3.2 Genomics and Proteomics
3.2.1 Genetic Variability and Disease
3.3 General Theory of Microarrays
3.3.1 DNA Microarrays
3.4 Protein Microarrays
3.5 Tissue Microarrays
3.6 Low Complexity Microarrays
3.7 Carbohydrate Microarrays

4. DNA Microarrays
4.1 DNA Microarray Technology Platforms
4.1.1 Microarray Technology
4.1.2 DNA Microarrays?Experimental Design
4.2 Types of Microarrays and Their Applications
4.2.1 Common Microarray Applications
4.3 Reasons Why Researchers Utilize DNA Microarrays
4.4 Factors for Difficulties Applying DNA Microarray Technology
4.5 Key Attributes of DNA Microarray Software
4.6 Microarray Technology in Treating Disease
4.6.1 High-Throughput Array Technology and Cancer
4.6.2 Microarray-Based Commercial Genotyping Activity
4.7 Commercialization of DNA Microarrays
4.8 Future Directions for DNA Microarray Technology
4.8.1 Microarrays vs. Next-Generation Sequencing
4.9 Emerging Microarray Trends
4.10 Emerging Microarray Applications
4.11 Key Points for Developing Microarray-Based Applications
4.12 Competitive Landscape for DNA Microarrays

5. Protein Microarrays
5.1 Types of Protein Microarrays
5.1.1 Forward Phase Microarrays
5.1.2 Reverse Phase Microarrays
5.1.3 Peptoid Arrays
5.1.4 Nucleic Acid Programmable Protein Arrays (NAPPA)
5.1.5 Antibody Microarrays
5.1.6 Classifying Protein Microarrays Based on Application
5.2 Critical Factors for Microarray Content
5.3 Key Findings on the Use of Microarrays
5.4 Advantages and Drivers
5.5 Limitations and Barriers to Commercialization
5.6 Key Experimental Parameters of Protein Microarray Technology
5.7 Reasons Why Researchers Utilize Protein Microarrays
5.8 Factors for Adoption of Protein Microarray Technology
5.9 Top Suppliers of Protein Microarray Slides and Products
5.10 Factors that Influence Sale Decisions
5.11 Future Innovations in Protein Microarray Technology
5.12 Protein Arrays Market Analysis

6. Current DNA Microarrays
6.1 Key Players
6.2 High Growth Applications
6.2.1 Microarray-Based Commercial Genotyping Activity
6.2.2 Location Analysis
6.2.3 Tiling Arrays
6.2.4 Epigenetic Mapping Arrays
6.3 Innovations in DNA Microarray Technology
6.4 Will Next-Generation Sequencing Replace DNA Microarray Technology?

7. Current Protein Microarrays
7.1 Protein Profiling Microarrays?Antibody Arrays
7.2 Protein Profiling Microarrays?Reverse Phase Microarrays
7.3 Multiplex Sandwich Microarrays?Planar
7.4 Multiplex Sandwich Immunoassays?Bead Based
7.5 Microarrays for Protein Function Studies
7.6 Specialized and High Growth Applications
7.6.1 Cytokine Arrays
7.6.2 Whole Proteome Arrays
7.7 Aptamer Arrays
7.8 Cell-Free Arrays
7.9 Protein Nanoarrays

8. Technology
8.1 Production of Microarrays
8.2 2D versus 3D Technology
8.3 Substrates and Surface Chemistries
8.4 Next-Generation Microarrays
8.5 Detection Methods
8.6 Instruments
8.7 Data Management and Informatics in Gene Expression
8.8 Software and Data Analysis
8.8.1 Supplier of DNA Microarray Analysis Software
8.8.2 Satisfaction with Software Features
8.8.3 Satisfaction with Software
8.8.4 Supplier Factors in Software Purchase Decision
8.8.5 SuppliersÍ Role in Improving Data Sharing for DNA Microarrays

9. Lab-on-a-Chip Technologies
9.1 Introduction to Lab-on-a-Chip
9.2 Lab-on-a-Chip Technology
9.3 Applications for Lab-on-a-Chip Technology
9.4 The Advantages of Lab-on-a-Chip Technology
9.5 Barriers to Widespread Adoption
9.6 Patent Portfolios
9.7 Trends and Outlook for Lab-on-a-Chip Technology
9.8 Key Players in Lab-on-a-Chip Industry
9.9 Lab-on-a-Chip Market Analysis

10. Applications
10.1 DNA Microarrays in Gene Expression
10.2 DNA Microarrays in SNP Analysis
10.3 DNA Microarrays in Cancer
10.3.1 Cancer and Fusion Genes
10.4 Protein Microarrays
10.4.1 Cytokine Applications
10.4.2 Protein Function
10.4.3 Protein Microarrays in Personalized Medicine
10.4.4 Protein-Protein Interactions
10.5 Target/Biomarker Discovery
10.6 Drug Discovery and Development (Gene and Protein Microarrays)
10.7 Clinical Diagnostics (Gene and Protein Microarrays)
10.8 RNA Microarrays
10.9 Oligo Microarrays
10.10 Yeast Microarrays
10.11 Antibody Arrays
10.12 Arrays for Toxicogenomics
10.13 Microbial Applications
10.14 The Market for Microbial Genotyping Products

11. Competitive Landscape
11.1 The Commercial Microarray Market
11.2 Sector Consolidation
11.3 Regulatory Matters
11.4 Legal Matters
11.5 Intellectual Property
11.6 Mergers, Acquisitions and Agreements

12. Company Profiles
12.1 Affymetrix
12.2 Agilent Technologies, Inc.
12.3 Arrayit Corporation
12.4 Applied Microarrays
12.5 AutoGenomics, Inc.
12.6 AyoxxA
12.7 BioCat GmbH
12.8 BioChain, Inc.
12.9 BioForce Nanosciences, Inc.
12.10 BioGenex
12.11 Biomedical Diagnostics (BMD)
12.12 Biolog, Inc.
12.13 bioM_rieux SA
12.14 Biometrix Technology, Inc.
12.15 Bio-Rad Laboratories
12.16 Cancer Genetics, Inc.
12.17 Cepheid, Inc.
12.18 Clontech Laboratories, Inc.
12.19 CombiMatrix Corporation
12.20 CYBRDI
12.21 DiagnoSwiss SA
12.22 Discerna
12.23 EMD Millipore
12.24 Eurogentec
12.25 Exiqon
12.26 Fluidigm Corporation
12.27 Gamida for Life Group
12.28 GE Healthcare
12.29 GGrace Bio-Labs
12.30 Greiner Bio-One
12.31 Healthcare IT, Inc.
12.32 Great Basin Corporation
12.33 Gyros AB
12.34 Illumina, Inc.
12.35 Imgenex Corp.
12.36 Immucor
12.37 InDevR
12.38 Isu Abxis Co., Ltd.
12.39 LC Sciences
12.40 Life Technologies/Applied Biosystems (AB)/Invitrogen
12.41 Lineagen, Inc.
12.42 Luminex Corporation
12.43 Maine Manufacturing, LLC
12.44 Meso Scale Discovery
12.45 Microarrays, Inc.
12.46 Microbionix
12.47 Mingyuan Medicare Development Company Limited
12.48 MiraiBio
12.49 Molecular Devices, LLC
12.50 Monogram Biosciences
12.51 Myriad Genetics, Inc.
12.52 NextGen Sciences PLC
12.53 One Lambda
12.54 OriGene Technologies
12.55 Orla Protein Technologies
12.56 Oxford Nanopore Technologies Ltd.
12.57 Oxford Gene Technology
12.58 PamGene BV
12.59 Partek, Inc.
12.60 Pepscan
12.61 Perkin Elmer, Inc.
12.62 Phalanx Biotech Group
12.63 PharmaSeq
12.64 Platypus Technologies, LLC
12.65 Protagen AG
12.66 ProteoGenix
12.67 ProteinOne, Inc.
12.68 QIAGEN
12.69 Radix BioSolutions
12.70 Randox Laboratories Ltd.
12.71 R&D Systems
12.72 RayBiotech
12.73 Roche NimbleGen, Inc.
12.74 Sequenom, Inc.
12.75 Sigma-Aldrich
12.76 SmartBead Technologies
12.77 SomaLogic
12.78 SQI Diagnostics
12.79 SuperBioChips Laboratories
12.80 Theranostic Health, Inc.
12.81 Toray Industries, Inc.
12.82 Trans Genic, Inc.
12.83 US Biomax
12.84 Veredus Laboratories Pte Ltd.
12.85 Zeptosens
12.86 Zeus Scientific, Inc.
12.87 Zyagen

INDEX OF FIGURES

Figure 2.1: Life Sciences Tools Markets, by Sector Served, 2012
Figure 2.2: Market Share within the Genetic Tools Market, 2012
Figure 2.3: Microarray Market Share, by Product Type
Figure 2.4: Global Market Share for Microarray Markets; by Region
Figure 3.1: Typical Two-Channel DNA Microarray Experiment
Figure 4.1: Segment of Double-Stranded DNA Showing the Base-Pair Relationship
Figure 5.1: Peptoid Arrays as Platforms for Biomarker Discovery
Figure 6.1: ChIP-on-Chip Experiment
Figure 6.2: The Choice between NGS and Microarrays: Rating by Application
Figure 7.1: Biomarker Discovery and Validation
Figure 7.2: Antibody Microarrays?Sandwich Detection Methods
Figure 7.3: Cytokines and Growth Factors: Sources of Microarrays for Cytokine Research
Figure 8.1: Sources of Variation in Microarray Data
Figure 9.1: A Visual Representation of Lab-on-a-Chip and Related Technologies
Figure 9.2: Unit Components Making up the Lab-on-a-Chip (LOAC) System
Figure 9.3: Market Share of Biochips Products by Type, 2013
Figure 10.1: Toxicogenomics: DNA Microarrays
Figure 10.2: Microbial Genotyping: Applications for DNA Microarrays
Figure 11.1: Microarray Patents by Region, up to 2013
Figure 11.2: Microarray Patents by Year, up to 2013

INDEX OF TABLES

Table 2.1: Key Assay Technologies for Molecular Diagnostics
Table 2.2: Summary of Molecular Diagnostics Testing Sectors
Table 2.3: Global Market for Molecular Diagnostics Testing, 2008-2018
Table 2.4: Global Microarray Market, 2010-2018
Table 2.5: Global Market size for DNA Microarrays, 2010-2018
Table 2.6: Microarray Market Drivers
Table 2.7: Leading Microarray Companies
Table 2.8: Microarray Market Leaders
Table 4.1: List of DNA Array Manufacturers
Table 4.2: Steps in the Design and Implementation of a DNA Microarray Experiment
Table 4.3: Microarray Applications
Table 4.4: DNA Microarray Applications
Table 4.5: List of Open Source and Commercially Available Software for Microarray Analysis
Table 4.6: Microarray Genetic Testing
Table 4.7: Microarray Market Barriers
Table 5.1: List of Commercial Antibody Microarrays
Table 5.2: Commercially Available Protein Arrays
Table 5.3: Critical Factors for Microarray Content
Table 5.4: Top Suppliers of Treated Protein Microarray Surfaces for Self-Printing
Table 5.5: Top Suppliers of Commercially Available Protein Microarrays
Table 5.6: Top Suppliers of Protein Microarray Platforms
Table 5.7: Global Market for Protein Microarrays, 2010-2018
Table 6.1: Types of DNA Microarrays
Table 7.1: Companies Offering Cytokine Microarrays
Table 8.1: Comparison of Microarray Platforms
Table 8.2: Microarray Instruments Offered by Affymetrix
Table 9.1: Categories of Biochips
Table 9.2: Applications of Lab-on-a-Chip Technology in Industry
Table 9.3: Lab-on-a-Chip Diagnostics
Table 9.4: Lab-on-a-Chip Patents, by Region, 2013
Table 9.5: List of Companies with Biochip Programs
Table 9.6: Global Market Size for Lab-on-a-Chip, 2009-2018
Table 10.1: HTS Microarray Market Size Projections, 2010-2017
Table 10.2: Protein Microarrays in Personalized Medicine
Table 11.1: Main Competitors in the Microarray Market, 2013
Table 11.2: Microarray Patents for Selected Companies, up to 2013

: Life Sciences Tools Markets, by Sector Served, 2012
Figure 2.2: Market Share within the Genetic Tools Market, 2012
Figure 2.3: Microarray Market Share, by Product Type
Figure 2.4: Global Market Share for Microarray Markets; by Region
Figure 3.1: Typical Two-Channel DNA Microarray Experiment
Figure 4.1: Segment of Double-Stranded DNA Showing the Base-Pair Relationship
Figure 5.1: Peptoid Arrays as Platforms for Biomarker Discovery
Figure 6.1: ChIP-on-Chip Experiment
Figure 6.2: The Choice between NGS and Microarrays: Rating by Application
Figure 7.1: Biomarker Discovery and Validation
Figure 7.2: Antibody Microarrays?Sandwich Detection Methods
Figure 7.3: Cytokines and Growth Factors: Sources of Microarrays for Cytokine Research
Figure 8.1: Sources of Variation in Microarray Data
Figure 9.1: A Visual Representation of Lab-on-a-Chip and Related Technologies
Figure 9.2: Unit Components Making up the Lab-on-a-Chip (LOAC) System
Figure 9.3: Market Share of Biochips Products by Type, 2013
Figure 10.1: Toxicogenomics: DNA Microarrays
Figure 10.2: Microbial Genotyping: Applications for DNA Microarrays
Figure 11.1: Microarray Patents by Region, up to 2013
Figure 11.2: Microarray Patents by Year, up to 2013

INDEX OF TABLES

Table 2.1: Key Assay Technologies for Molecular Diagnostics
Table 2.2: Summary of Molecular Diagnostics Testing Sectors
Table 2.3: Global Market for Molecular Diagnostics Testing, 2008-2018
Table 2.4: Global Microarray Market, 2010-2018
Table 2.5: Global Market size for DNA Microarrays, 2010-2018
Table 2.6: Microarray Market Drivers
Table 2.7: Leading Microarray Companies
Table 2.8: Microarray Market Leaders
Table 4.1: List of DNA Array Manufacturers
Table 4.2: Steps in the Design and Implementation of a DNA Microarray Experiment
Table 4.3: Microarray Applications
Table 4.4: DNA Microarray Applications
Table 4.5: List of Open Source and Commercially Available Software for Microarray Analysis
Table 4.6: Microarray Genetic Testing
Table 4.7: Microarray Market Barriers
Table 5.1: List of Commercial Antibody Microarrays
Table 5.2: Commercially Available Protein Arrays
Table 5.3: Critical Factors for Microarray Content
Table 5.4: Top Suppliers of Treated Protein Microarray Surfaces for Self-Printing
Table 5.5: Top Suppliers of Commercially Available Protein Microarrays
Table 5.6: Top Suppliers of Protein Microarray Platforms
Table 5.7: Global Market for Protein Microarrays, 2010-2018
Table 6.1: Types of DNA Microarrays
Table 7.1: Companies Offering Cytokine Microarrays
Table 8.1: Comparison of Microarray Platforms
Table 8.2: Microarray Instruments Offered by Affymetrix
Table 9.1: Categories of Biochips
Table 9.2: Applications of Lab-on-a-Chip Technology in Industry
Table 9.3: Lab-on-a-Chip Diagnostics
Table 9.4: Lab-on-a-Chip Patents, by Region, 2013
Table 9.5: List of Companies with Biochip Programs
Table 9.6: Global Market Size for Lab-on-a-Chip, 2009-2018
Table 10.1: HTS Microarray Market Size Projections, 2010-2017
Table 10.2: Protein Microarrays in Personalized Medicine
Table 11.1: Main Competitors in the Microarray Market, 2013
Table 11.2: Microarray Patents for Selected Companies, up to 2013

Global Microarray Market to Catapult to $7.4 Billion by 2018

- Affymetrix
- Agilent Technologies, Inc
- Applied Microarrays
- Arrayit Corporation
- AutoGenomics, Inc
- AyoxxA
- Bio-Rad Laboratories
- BioCat GmbH
- BioChain, Inc
- BioForce Nanosciences, Inc
- BioGenex
- Biolog, Inc
- Biomedical Diagnostics (BMD)
- Biometrix Technology, Inc
- bioM_rieux SA
- CYBRDI
- Cancer Genetics, Inc
- Cepheid, Inc
- Clontech Laboratories, Inc
- CombiMatrix Corporation
- DiagnoSwiss SA
- Discerna
- EMD Millipore
- Eurogentec
- Exiqon
- Fluidigm Corporation
- GE Healthcare
- GGrace Bio-Labs
- Gamida for Life Group
- Great Basin Corporation
- Greiner Bio-One
- Gyros AB
- Healthcare IT, Inc
- Illumina, Inc
- Imgenex Corp
- Immucor
- InDevR
- Isu Abxis Co, Ltd
- LC Sciences
- Life Technologies/Applied Biosystems (AB)/Invitrogen
- Lineagen, Inc
- Luminex Corporation
- Maine Manufacturing, LLC
- Meso Scale Discovery
- Microarrays, Inc
- Microbionix
- Mingyuan Medicare Development Company Limited
- MiraiBio
- Molecular Devices, LLC
- Monogram Biosciences
- Myriad Genetics, Inc
- NextGen Sciences PLC
- One Lambda
- OriGene Technologies
- Orla Protein Technologies
- Oxford Gene Technology
- Oxford Nanopore Technologies Ltd
- PamGene BV
- Partek, Inc
- Pepscan
- Perkin Elmer, Inc
- Phalanx Biotech Group
- PharmaSeq
- Platypus Technologies, LLC
- Protagen AG
- ProteinOne, Inc
- ProteoGenix
- QIAGEN
- R&D Systems
- Radix BioSolutions
- Randox Laboratories Ltd
- RayBiotech
- Roche NimbleGen, Inc
- SQI Diagnostics
- Sequenom, Inc
- Sigma-Aldrich
- SmartBead Technologies
- SomaLogic
- SuperBioChips Laboratories
- Theranostic Health, Inc
- Toray Industries, Inc
- Trans Genic, Inc
- US Biomax
- Veredus Laboratories Pte Ltd
- Zeptosens
- Zeus Scientific, Inc
- Zyagen

Note: Product cover images may vary from those shown

ALSO AVAILABLE

  • Genetics Bundle - Product Thumbnail Image

    Genetics Bundle

    • Language: English
    • 1807 Pages
    • Published: June 2012
    • Region: Global
    FROM
  • DNA Sequencing and PCR Markets - Product Thumbnail Image

    DNA Sequencing and PCR Markets

    • Language: English
    • 176 Pages
    • Published: November 2013
    • Region: Global
    FROM
  • Personalized Medicine - Product Thumbnail Image

    Personalized Medicine

    • Language: English
    • 87 Pages
    • Published: August 2007
    • Region: Global
    FROM
  • Gene Expression Reagents Markets - Product Thumbnail Image

    Gene Expression Reagents Markets

    • Language: English
    • 113 Pages
    • Published: April 2007
    • Region: Global
    FROM
  • Genomics World Markets - Product Thumbnail Image

    Genomics World Markets

    • Language: English
    • 160 Pages
    • Published: May 2008
    • Region: Global
    FROM
  • Bioinformatics Markets - Product Thumbnail Image

    Bioinformatics Markets

    • Language: English
    • 224 Pages
    • Published: March 2009
    • Region: Global
    FROM
  • RNA Interference Markets - Product Thumbnail Image

    RNA Interference Markets

    • Language: English
    • 147 Pages
    • Published: December 2008
    • Region: Global
    FROM

RELATED PRODUCTS

Our Clients

Our clients' logos